I Introduction
II Worldwide Market Overview
1 Market Overview
2 Worldwide Market Structure
3 Worldwide Market Size and Growth
III Major Product Development Opportunities
A Reagent Kits and Test Systems/Panels
B Instrumentation
C Computers, Software and Automation
D Auxiliary Products
IV Design Criteria for Decentralized Testing Products
V Alternative Market Penetration Strategies
A Internal Development
B Collaborative Arrangements
C University Contracts
D Distribution Strategies
VI Potential Market Entry Barriers and Risks
A Market Maturity
B Cost Containment
C Competition
D Technological Edge and Limitations
E Patent Protection
F Regulatory Constraints
G Decentralized Testing Market Challenges


VII Worldwide Market and Technology Overview
A Cancer Statistics and Etiology
1 Breast Cancer
2 Lung Cancer
3 Colon and Rectum Cancer
4 Prostate Cancer
5 Stomach Cancer
6 Leukemia
7 Lymphoma
8 Oral Cancer
9 Skin Cancer
10 Uterine Cancer
11 Ovarian Cancer
12 Bladder Cancer
B Major Current And Emerging Cancer Diagnostic Tests
1 Introduction
2 Tumor Marker Classification
3 ACTH
4 Alpha-Fetoprotein (AFP)
5 Beta-2 Microglobulin
6 CA 15-3/2729
7 CA 19-9
8 CA-125
9 Calcitonin
10 Carcinoembrionic Antigen (CEA)
11 Estrogen and Progesterone Receptors
12 Ferritin
13 Gastrin
14 Human Chorionic Gonadotropin (HCG)
15 Insulin
16 NSE
17 Occult Blood
18 PAP Smear/HPV
19 Prostatic Acid Phosphatase (PAP)
20 Prostate-Specific Antigen (PSA)
21 Squamous Cell Carcinoma Antigen (SCC)
22 T and B Lymphocytes

23 TdT
24 Thyroglobulin
25 Tissue Polypeptide Antigen (TPA)
26 Biochemical Tumor Markers
27 Oncogenes
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP-17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src
28 Polypeptide Growth Factors
- Basic Fibroblast Growth Factor
- Beta-TGF
- Cachectin (TNT)
- Calmodulin
- ECFR
- Nerve Growth Factor (NGF)
- Epidermal Growth Factor (EGF)
- Ornithine Decarboxylase
- Transferrin
- Transforming Growth Factor-Alpha


29 Ectopic Hormones
30 Colony Stimulating Factors
31 Lymphokines
- Alpha-Interferon
- B Cell Growth Factors
- B Cell Growth Factor (BCGF)
- Gamma-Interferon
- Interleukin-1 (IL-1)
- Macrophage Activating Factor
32 Immunohistochemical Stains
33 Emerging Tumor Markers
- N-Acetylglucosamine
- Actin
- Alpha-Actin
- Antineuronal Antibodies
- 7B2
- B723
- Bax
- BCD-F9
- BLCA-4
- Blood Group Antigens A,B,H
- CA 50
- CA 72-4/TAG-72
- CA 195
- CA-242
- CA-549
- CAM 26
- CAR-3
- Cathepsin-D
- Chromogranin A and B
- Cluster 1 Antigen
- Cluster-5/5A Antigen
- CTA
- CU18
- DR-70
- DU-PAN-2
- Endometrial Bleeding Associated Factor
- Endostatin
- Epithelial Membrane Antigen
- Feulgen Hydrolysis
- Fibronectin

- FSH
- (1->3)-L-fucosyltransferase
- Gastrin-Releasing Peptide (GRP)
- GDCFP-15
- Glucagon
- Glycoamines
- H23
- Her-2
- Human Carcinoma Antigen
- HPA
- HSP27
- Intermediate Filaments
- Cytokeratins/CK18/Cyfra 21-1
- Desmin
- Gliofibrillary Acid Protein
- Neurofilaments
- Vimentin
- KA 93
- Kinases
- KP16D3
- LAI
- Leukocyte Common Antigen
- Lewis Antigens
- Lysophosphatidic Acid (LPA)
- Ma 695/Ma 552
- MABDF3
- MAG
- ME1
- Minactivin
- MN/CA9
- MSA
- Mucin Cancer Antigen (MCA)
- Multiple Tumor Suppressor 1
- Myosin
- NEA-130
- NMP22
- OA-519
- Opioid Peptides
- P-glycoprotein
- Pancreatic Oncofetal Antigen (POA)
- Placental Lactogen
- PR92

- Proliferative Index, Ki-67
- Px
- RB Inactivation/Deletion
- Ret
- SCCL 175
- Selectin
- Sialic Acid
- Sialyl SSEA-1/SLX
- SN10
- Somatostatin
- TA-90
- TABA
- Tachykinin
- TAG 12
- TPS
- Troponin
- Tubulin
- VCAM
- VEGF
- Villen
C Cancer Diagnostic Testing Instrumentation Review and Market Needs
D Current and Emerging Cancer Diagnostic Technologies
1 Monoclonal and Polyclonal Antibodies
2 Immunoassays
3 Molecular Diagnostics
4 Chromosome Analysis
a Chronic Myelogenous Leukemia (CML)
b Acute Myeloid Leukemia (AML)
c Acute Lymphoblastic Leukemia (ALL)
d Malignant Lymphomas Lymphoid Malignancies
e Chronic Lymphocytic Leukemia (CLL)
f Solid Cancers
g Chromosomal Translocation and Oncogenes
5 Artificial Intelligence
6 Flow Cytometry
7 Two Dimensional Gel Electrophoresis (2-DGE)
8 Biosensors
9 Competing/Complementing Technologies
E Personal Testing

VIII France Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
IX Germany Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
X Italy Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XI Japan Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XII Spain Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test

XIII UK Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XIV US Cancer Diagnostics Market
A Executive Summary
B Business Environment
C Market Structure
D Market Size, Test Volume and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XV Competitive Profiles
- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences

- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Thermo
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

XVI Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications

List of Tables


Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/2729 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests

Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast
by Market Segment
France, Estimated Cancer Death Rates
Per 100,000 Population
France, Laboratories Performing Tumor
Marker Tests by Market Segment
France, Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
France, Commercial/Private Laboratories
Performing Tumor Markers by Annual Test Volume
France, Total Tumor Marker Test Volume
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Test Volume Forecast
France, Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecast
France, Total Tumor Marker Sales Major Tumor
Forecast by Market Segment
France, All Market Segments Major Tumor
Marker Sales Forecast by Test
France, Hospital Laboratories Major Tumor
Marker Sales Forecast by Test